Overall Technical outlook

Price Summary

On 2025-08-14, SUNPHARMA's stock started at 1639.8, reached a high of 1651.1, fell to 1632.2, and ended 0.1% up at 1641.4, with 1737976 shares traded.
During the past 52 weeks, the highest stock price was 1948.7, and the lowest was 1566.5.
Future price predictions suggest a range between 1525.0 and 2450.0, with an average expected price of 1941.4054, as per 37 analysts.

Technicals

Support and Resistance: The price for SUNPHARMA at 1641.4 finds support at 1593.25 and resistance at 1647.6. This suggests a trading range, where 1593.25 serves as a support level and 1647.6 acts as a resistance point, potentially capping further gains.
SUNPHARMA supportResistance b0b2a2
Support/Resistance for SUNPHARMA


Aroon: The AROON is showing a neutral stance, not indicating a clear upward or downward trend for Sun Pharmaceutical Industries Limited. This suggests a period of market balance, where neither side is showing dominance.
SUNPHARMA aroon b0b2a2
Aroon chart for Sun Pharmaceutical Industries Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position for Sun Pharmaceutical Industries Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
SUNPHARMA bbands b0b2a2
Bolinger Bands chart for Sun Pharmaceutical Industries Limited


Parabolic SAR: The PSAR for SUNPHARMA continues to signal a bearish stance, reinforcing a resistance level that could restrict upward movement. This resistance suggests that the market may remain under bearish pressure, with limited potential for breaking higher.
SUNPHARMA psar b0b2a2
Parabolic Stop and Reverse chart for Sun Pharmaceutical Industries Limited


Stochastic: The STOCHASTIC is showing a neutral stance, not indicating a clear upward or downward trend for Sun Pharmaceutical Industries Limited. This suggests a period of market balance, where neither side is showing dominance.
SUNPHARMA stoch b0b2a2
Stochastic chart for Sun Pharmaceutical Industries Limited


Tripple Moving Agerage: The moving averages for SUNPHARMA for the 20-50-100 periods point to a bullish trend, but the slopes of the faster averages suggest this strength may be waning. The potential for a reversal is becoming apparent, as the shorter-term averages indicate that the upward momentum could be weakening, signaling a possible trend change.
SUNPHARMA trippleSMA b0b2a2
Tripple SMA chart for Sun Pharmaceutical Industries Limited


Analyzing the technical indicators of a company, such as stock price and trading volume, requires first understanding its fundamentals. These fundamentals include profitability, growth potential, and market position. Furthermore, knowing the broader industry trends and competitive landscape provides critical context. When both the company's internal data and the external environment are considered, it allows for more meaningful conclusions about the company's technical performance and future trajectory.